Patent holdings for IPC class A61K 31/437

Total number of patents in this class: 9502

10-year publication summary

687
685
710
762
795
794
746
772
620
173
2015 2016 2017 2018 2019 2020 2021 2022 2023 2024

Principal owners for this class

Owner
All patents
This class
Bristol-myers Squibb Company
5080
194
F. Hoffmann-La Roche AG
7958
134
Takeda Pharmaceutical Company Limited
2961
131
Novartis AG
11238
120
Incyte Corporation
918
116
Genentech, Inc.
3742
113
Janssen Pharmaceutica N.V.
3839
108
Merck Sharp & Dohme LLC
3689
95
Boehringer Ingelheim International GmbH
4629
93
Merck Patent GmbH
5909
88
Gilead Sciences, Inc.
1879
71
Bayer Pharma AG
1096
70
Pfizer Inc.
3322
67
Abbvie Inc.
1808
64
Dana-Farber Cancer Institute, Inc.
2455
64
Hoffmann-La Roche Inc.
3060
59
Galapagos NV
304
59
The Regents of the University of California
18943
58
Plexxikon Inc.
168
58
AstraZeneca AB
3042
56
Other owners 7684